Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
943 of 1,108 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,448 total, page 8 of 29
Evaluating Emetine for Viral Outbreaks (EVOLVE)
NCT05889793
Piloting a Web Resource for Pregnancy OUD in Jail
NCT05853289
ALIGN: Aligning Medications With What Matters Most (Demonstration)
NCT06335953
Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)
NCT06445127
Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community
NCT06289192
Tobacco Cessation in Public Housing
NCT04889638
Assessing Effectiveness of a Diabetes Navigator in Increasing Progression of Advanced Diabetes Technologies
NCT06229236
Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck
NCT05956795
Optimization Post-TAVR to IMprove Activity Levels (OPTIMAL Study)
NCT06106451
Reducing Silica Exposure Among Brick Kiln Workers in Nepal
NCT06090370
Evaluation of Efficacy and Comfort: A Trial on the Incrediwear Back Brace in Patients With Chronic Lower Back Pain
NCT06126887
Study Examining the Effect of a Novel Cannulation Knife on User Satisfaction and Common Central Venous Catheter Insertion Complications
NCT06310174
Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid
NCT05611905
HEARS-SLP: Providing SLP-Delivered Hearing Health Care to Individuals With Cognitive Impairment
NCT06008782
Hearing Health for Korean American Older Adults With Mild Cognitive Impairment
NCT06068933
Enhanced Recovery After Surgery (ERAS) for Ambulatory TURBT
NCT05905276
The Impact of Routine Follow-up Contacts After a Pediatric ED Visit for Youth With Suicide Risk
NCT06616701
Examining the Effect of Nutritional Supplementation on Skeletal Muscle Mass in Patients Awaiting Lung Transplant
NCT04522388
Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease
NCT05978804
Analysis of Cellular Kinases and Aging in PBMCs and Colorectal Tissue
NCT06132386
A National Survey on the Prevalence and Impact of Multiple Pharmacy Use in Specialty Pharmacy
NCT05035225
Patient Centered Mobile Health Technology Enabled Atrial Fibrillation Management
NCT05400837
Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
NCT05711719
Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes
NCT05442112
Clinical Practice Guidelines Versus Decision-support for Latent Tuberculosis Infection (LTBI) Management
NCT05772065
Evaluation of an Investigational Wearable Vital Signs Monitoring Device in Healthy Infants
NCT05910320
Shared Decision Making About Medication Use for People With Multiple Health Problems
NCT05156073
Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET
NCT05609552
Messaging Strategies to Reduce Breast Cancer Over-screening in Older Women
NCT05821023
Social Risk Score, Clinical Decision Support Tool and Closed Loop Referral for Social Risk Screen and Referral
NCT05574699
Impact of a Corrie Cardiac Rehabilitation Program
NCT05238103
Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxia
NCT05436262
iTBS in Bipolar I Depression
NCT05375214
Quantifying Myofascial Dysfunction in Post-Stroke Pain
NCT05762679
Cryoprobe Versus Forceps for Transbronchial Biopsy
NCT05751278
Conditioned Open-label Placebo (COLP) for Peri-operative Pain Management in Patients With Head and Neck Cancer
NCT04973748
Chemosensory Dysfunction and Recovery in Endoscopic Endonasal Skull Base Surgery
NCT05912881
The Pharmacodynamics of Cannabinoid-Caffeine Combinations
NCT05478863
Sight and Hearing Investigation Into Effects on Delirium
NCT06176625
CAPABLE Care Partner Pilot Study
NCT05670639
Optimizing Cerebral Autoregulation During Surgery
NCT05308290
Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients
NCT05611892
Use of Real-Time Functional Magnetic Resonance Imaging Neurofeedback to Improve Motor Function in Cerebellar Ataxia
NCT05436249
Strict Need to Void After Same-day Discharge, Non-urogynecologic, Minimally Invasive Hysterectomy
NCT05108506
Concurrent TMS and EEG Pilot Study
NCT05665634
Suvorexant for Opioid/Stimulant Co-use
NCT05546515
Living With Multimorbidity: CO-ORDINATE Program
NCT05985044
Tetracycline Treatment Tolerability Trial
NCT05219929
Women and Child, Safety, Health, and Empowerment
NCT05940129
Difficult Encounters in Pain Medicine
NCT05585619
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johns Hopkins University: open-pipeline peers nationwide
Peers matched on 1,448 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Johns Hopkins University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,448 trials (± recruiting share)
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Yale University · 1,492 trials · 17% recruiting
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Seattle Children's Hospital · 17% recruiting · 168 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
- Virginia Polytechnic Institute and State University · 17% recruiting · 104 trials
Related
What to do with this Johns Hopkins University page
1,448 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins University or any single study.
- 250 of Johns Hopkins University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Johns Hopkins University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Johns Hopkins University pipeline card: 1,448 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.